# A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin

> **NCT04770532** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 526 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin degludec
- **DRUG:** Insulin Icodec

## Key facts

- **NCT ID:** NCT04770532
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-05
- **Primary completion:** 2022-01-27
- **Final completion:** 2022-03-01
- **Target enrollment:** 526 (ACTUAL)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04770532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04770532, "A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04770532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*